Pfizer Inc. (BVMF:PFIZ34)

Market Cap	721.32B
Revenue (ttm)	349.70B
Net Income (ttm)	58.90B
Shares Out	n/a
EPS (ttm)	10.38
PE Ratio	12.25
Forward PE	8.41
Dividend	1.65 (5.21%)
Ex-Dividend Date	Jul 24, 2025

Volume	43,978
Average Volume	8,689
Open	32.13
Previous Close	31.65
Day's Range	31.78 - 32.31
52-Week Range	30.84 - 42.45
Beta	0.46
RSI	38.80
Earnings Date	Oct 28, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: PFIZ34

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD